## Core Concept
Polycythemia vera (PV) is a type of myeloproliferative neoplasm characterized by the excessive production of red blood cells, white blood cells, and platelets. This condition is often associated with mutations in the JAK2 gene. The disorder can lead to increased blood viscosity, which may cause thrombotic events.

## Why the Correct Answer is Right
The correct answer choice is not provided, but generally, polycythemia vera is associated with an increased risk of thrombosis, splenomegaly, and a high risk of transformation to acute myeloid leukemia. A key feature of PV is the presence of the JAK2 V617F mutation in more than 95% of patients, which leads to the activation of the JAK/STAT signaling pathway and subsequent overproduction of blood cells.

## Why Each Wrong Option is Incorrect
- **Option A:** Typically, polycythemia vera is indeed associated with an elevated red cell mass, which is a diagnostic criterion. Therefore, any statement contradicting this fundamental aspect would be incorrect.
- **Option B:** This option is not provided, but if it stated something commonly true about PV, such as increased erythropoietin-independent erythropoiesis or the presence of the JAK2 mutation, it would not be the correct answer if the question seeks what is "not true."
- **Option C:** Without specifics, if this option suggested a characteristic not commonly seen in PV, such as a lack of splenomegaly or a very low risk of thrombosis, it could potentially be correct depending on its content.
- **Option D:** Similarly, if this option presented a feature not typically associated with PV, it could be considered.

## Clinical Pearl / High-Yield Fact
A key clinical pearl for polycythemia vera is that phlebotomy is a mainstay of treatment to reduce blood viscosity and prevent thrombotic complications. Regular phlebotomies can help manage the condition and reduce the risk of complications.

## Correct Answer: D. Increased levels of erythropoietin are not typically seen.